Wietecha LA, Kuca B, Case MG, et al.Phase-3 study (SPARTAN) of Lasmiditan compared to placebo for acute treatment of migraine. EAN 2018; abstract O405.
Belangrijke stappen in onderzoek behandeling MS en alzheimer
sep 2019 | Dementie, Multipele Sclerose